Verve Therapeutics, Inc. (NASDAQ:VERV) is one of the Stocks With Huge Catalysts on the Horizon. On April 14, Verve ...

Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc.

Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.

Eli Lilly and Company has acquired Verve Therapeutics Inc., a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.

Eli Lilly's acquisition of Vere Therapeutics promises to revolutionize cardiovascular care with innovative one-time gene ...

Verve Therapeutics ( (VERV)) has shared an announcement. Verve Therapeutics announced the establishment of a retention bonus program for its employees, granting significant retention awards to key ...

Eli Lilly stock dips despite strong Q2 results. Read my insights on obesity drug market dominance and why this selloff in LLY ...

Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics ...

Verve Therapeutics , Inc. (NASDAQ:VERV), whose stock has surged over 100% in the past six months according to InvestingPro data, announced Monday that it has established a retention bonus program ...

Verve Therapeutics , Inc. (NASDAQ: VERV), whose stock has surged over 100% in the past six months according to InvestingPro data, announced Monday that it has established a retention bonus program for ...

The primary safety risks associated with gene therapy include immune reactions and off-target effects in unintended organs, ...